Abera Bioscience
Showcase Sponsor
Abera is a biotechnology company that develops vaccine candidates based on
proprietary technologies and platforms. The Company’s unique expertise in
Biochemistry and Molecular Microbiology is based on many years of research
and has generated a patented platform technology.
Abera brings Outer Membrane Vesicle (OMV) technology to the next level by
decorating their surface with antigens at a high density. Abera has adapted a
natural system for bacterial protein secretion into the most efficient and versatile system for surface display of antigens known today.
The high-density surface display of antigens reached, combined with the selfadjuvanting character of Abera’s platform allows for the generation of potent multivalent vaccines that are suitable for mucosal administration. Extensive optimization of OMV production and antigen display efficiency has led to robust and scalable procedures to produce a vaccine at a low cost within 30 days.
proprietary technologies and platforms. The Company’s unique expertise in
Biochemistry and Molecular Microbiology is based on many years of research
and has generated a patented platform technology.
Abera brings Outer Membrane Vesicle (OMV) technology to the next level by
decorating their surface with antigens at a high density. Abera has adapted a
natural system for bacterial protein secretion into the most efficient and versatile system for surface display of antigens known today.
The high-density surface display of antigens reached, combined with the selfadjuvanting character of Abera’s platform allows for the generation of potent multivalent vaccines that are suitable for mucosal administration. Extensive optimization of OMV production and antigen display efficiency has led to robust and scalable procedures to produce a vaccine at a low cost within 30 days.
sponsors
co-located with